← All trials
NCT03005483
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2014
- Primary completion
- Jan 1, 2015
- Completion date
- May 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Hospital Infantil Albert SabinLead sponsor
- Hospital Infantil Albert SabinReponsible party - principal investigator
- Fortaleza UniversityStudy chair
- Fortaleza UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.